P物质和辣椒素诱导的大鼠膝关节机械性痛觉过敏；缓激肽B1和B2受体的作用
Substance P and capsaicin-induced mechanical hyperalgesia in the rat knee joint; the involvement of bradykinin B1 and B2 receptors.
作者信息
Davis A J, Perkins M N
机构信息
Sandoz Institute for Medical Research, London.
出版信息
Br J Pharmacol. 1996 Aug;118(8):2206-12. doi: 10.1111/j.1476-5381.1996.tb15664.x.
Abstract
- Substance P (SP) and capsaicin induced a mechanical hyperalgesia when injected into rat knee joints. 2. The NK1 receptor antagonists CP 99994 (10-100 nmol) and RP 67580 (0.1-1 nmol) blocked the development of, and also reversed, SP-induced hyperalgesia. Capsaicin (10 nmol)-induced hyperalgesia was blocked by capsazepine (0.5-5 nmol). 3. Capsaicin-induced hyperalgesia was prevented and reversed by the NK1 receptor antagonists CP 99994 (100 nmol) and RP 67580 (1 nmol). 4. The bradykinin B2 receptor antagonist icatibant (5 pmol) blocked the development of both SP and capsaicin-induced hyperalgesia. Icatibant (100 pmol kg-1, i.v.) also reversed an established SP and capsaicin-induced hyperalgesia. 5. Both low dose SP (1 nmol) and capsaicin (1 nmol)-induced hyperalgesia were potentiated by the kininase II inhibitor captopril (100 micrograms). 6. The B1 receptor antagonists desArg9Leu8-bradykinin (BK) (0.5-5 nmol) and desArg10[Hoe 140] (5-50 pmol) only blocked the development of SP-induced hyperalgesia for 30 min after administration. desArg9Leu8-BK (10 nmol kg-1 i.v.) did not reverse an established SP-induced hyperalgesia. 7. Capsaicin-induced hyperalgesia was blocked by desArg9Leu8-BK (0.5 nmol) and this antagonist also reversed an established capsaicin-induced hyperalgesia. 8. Interleukin-1 receptor antagonist (IL-1ra 0.1 microgram) reduced the development of SP-induced hyperalgesia up to 4 h after administration, but did not reverse an established hyperalgesia. IL-1ra (0.1 microgram) also blocked the development of and reversed an established capsaicin-induced hyperalgesia. 9. Indomethacin pretreatment (1 mg kg-1, s.c.) did not reduce the development of either SP- or capsaicin-induced hyperalgesia but following indomethacin-pretreatment desArg9Leu8-BK (10 nmol kg-1, i.v.) failed to reverse a capsaicin-induced hyperalgesia. 10. In conclusion, both SP and capsaicin can induce behavioural hyperalgesia when injected into the knee joint of rats. In addition, blockade of NK1, bradykinin B1, B2 and IL-1 beta receptors can substantially modulate this hyperalgesia.
摘要
- P物质（SP）和辣椒素注入大鼠膝关节时可诱发机械性痛觉过敏。2. NK1受体拮抗剂CP 99994（10 - 100纳摩尔）和RP 67580（0.1 - 1纳摩尔）可阻止SP诱发的痛觉过敏的发展，并使其逆转。辣椒素（10纳摩尔）诱发的痛觉过敏可被辣椒素受体拮抗剂（0.5 - 5纳摩尔）阻断。3. NK1受体拮抗剂CP 99994（100纳摩尔）和RP 67580（1纳摩尔）可预防并逆转辣椒素诱发的痛觉过敏。4. 缓激肽B2受体拮抗剂艾替班特（5皮摩尔）可阻止SP和辣椒素诱发的痛觉过敏的发展。艾替班特（100皮摩尔/千克，静脉注射）也可逆转已形成的SP和辣椒素诱发的痛觉过敏。5. 低剂量SP（1纳摩尔）和辣椒素（1纳摩尔）诱发的痛觉过敏可被激肽酶II抑制剂卡托普利（100微克）增强。6. B1受体拮抗剂去精氨酸9亮氨酸8 - 缓激肽（BK）（0.5 - 5纳摩尔）和去精氨酸10[Hoe 140]（5 - 50皮摩尔）仅在给药后30分钟内阻止SP诱发的痛觉过敏的发展。去精氨酸9亮氨酸8 - BK（10纳摩尔/千克，静脉注射）不能逆转已形成的SP诱发的痛觉过敏。7. 去精氨酸9亮氨酸8 - BK（0.5纳摩尔）可阻断辣椒素诱发的痛觉过敏，该拮抗剂也可逆转已形成的辣椒素诱发的痛觉过敏。8. 白细胞介素 - 1受体拮抗剂（IL - 1ra 0.1微克）在给药后长达4小时内可减少SP诱发的痛觉过敏的发展，但不能逆转已形成的痛觉过敏。IL - 1ra（0.1微克）也可阻止并逆转已形成的辣椒素诱发的痛觉过敏。9. 吲哚美辛预处理（1毫克/千克，皮下注射）不能减少SP或辣椒素诱发的痛觉过敏的发展，但在吲哚美辛预处理后，去精氨酸9亮氨酸8 - BK（10纳摩尔/千克，静脉注射）不能逆转辣椒素诱发的痛觉过敏。10. 总之，SP和辣椒素注入大鼠膝关节时均可诱发行为性痛觉过敏。此外，阻断NK1、缓激肽B1、B2和IL - 1β受体可显著调节这种痛觉过敏。
相似文献
1
Substance P and capsaicin-induced mechanical hyperalgesia in the rat knee joint; the involvement of bradykinin B1 and B2 receptors.
Br J Pharmacol. 1996 Aug;118(8):2206-12. doi: 10.1111/j.1476-5381.1996.tb15664.x.
2
The involvement of bradykinin B1 and B2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat.
Br J Pharmacol. 1994 Sep;113(1):63-8. doi: 10.1111/j.1476-5381.1994.tb16174.x.
3
Mediation by bradykinin of rat paw oedema induced by collagenase from Clostridium histolyticum.
Br J Pharmacol. 1994 Jun;112(2):453-60. doi: 10.1111/j.1476-5381.1994.tb13094.x.
4
Pharmacological analysis of the local and reflex responses to bradykinin on rat urinary bladder motility in vivo.
Br J Pharmacol. 1995 Feb;114(3):708-14. doi: 10.1111/j.1476-5381.1995.tb17196.x.
5
Involvement of B1 and B2 receptors in bradykinin-induced rat paw oedema.
Br J Pharmacol. 1995 Mar;114(5):1005-13. doi: 10.1111/j.1476-5381.1995.tb13305.x.
6
Bradykinin B1 and B2 receptor mechanisms and cytokine-induced hyperalgesia in the rat.
Can J Physiol Pharmacol. 1995 Jul;73(7):832-6. doi: 10.1139/y95-113.
7
The induction of des-Arg9-bradykinin-mediated hyperalgesia in the rat by inflammatory stimuli.
Braz J Med Biol Res. 1994 Aug;27(8):1793-802.
8
Upregulation of B1 receptor mediating des-Arg9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin.
Br J Pharmacol. 1996 Mar;117(5):793-8. doi: 10.1111/j.1476-5381.1996.tb15262.x.
9
Induction of bradykinin B1 receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat.
Br J Pharmacol. 1993 Dec;110(4):1441-4. doi: 10.1111/j.1476-5381.1993.tb13982.x.
10
Studies on the vascular permeability induced by intrathecal substance P and bradykinin in the rat.
Eur J Pharmacol. 1990 Aug 2;184(1):9-20. doi: 10.1016/0014-2999(90)90662-p.
引用本文的文献
1
Mechanisms underlying mechanical sensitization induced by complement C5a: the roles of macrophages, TRPV1, and calcitonin gene-related peptide receptors.
Pain. 2019 Mar;160(3):702-711. doi: 10.1097/j.pain.0000000000001449.
2
Role of capsaicin-sensitive nerves and tachykinins in mast cell tryptase-induced inflammation of murine knees.
Inflamm Res. 2016 Sep;65(9):725-36. doi: 10.1007/s00011-016-0954-x. Epub 2016 Jun 1.
3
The thermo-TRP ion channel family: properties and therapeutic implications.
Br J Pharmacol. 2012 Feb;165(4):787-801. doi: 10.1111/j.1476-5381.2011.01601.x.
4
Influence of systemic immune and cytokine responses during the acute phase of zoster on the development of postherpetic neuralgia.
J Zhejiang Univ Sci B. 2009 Aug;10(8):625-30. doi: 10.1631/jzus.B0920049.
5
Capsaicin-evoked iCGRP release from human dental pulp: a model system for the study of peripheral neuropeptide secretion in normal healthy tissue.
Pain. 2009 Aug;144(3):253-261. doi: 10.1016/j.pain.2009.03.027. Epub 2009 May 9.
6
Chemokines: integrators of pain and inflammation.
Nat Rev Drug Discov. 2005 Oct;4(10):834-44. doi: 10.1038/nrd1852.
7
Mechanical stimulation activates small fiber mediated nociceptive responses in the nucleus gigantocellularis.
Exp Brain Res. 2003 Apr;149(4):505-11. doi: 10.1007/s00221-003-1381-0. Epub 2003 Mar 4.
本文引用的文献
1
Bilateral changes of substance P-, neurokinin A-, calcitonin gene-related peptide- and neuropeptide Y-like immunoreactivity in rat knee joint synovial fluid during acute monoarthritis.
Neurosci Lett. 1993 Apr 16;153(1):37-40. doi: 10.1016/0304-3940(93)90071-r.
2
Antinociceptive activity of the bradykinin B1 and B2 receptor antagonists, des-Arg9, [Leu8]-BK and HOE 140, in two models of persistent hyperalgesia in the rat.
Pain. 1993 May;53(2):191-197. doi: 10.1016/0304-3959(93)90080-9.
3
Antinociceptive activity of NK1 receptor antagonists: non-specific effects of racemic RP67580.
Br J Pharmacol. 1993 Dec;110(4):1607-13. doi: 10.1111/j.1476-5381.1993.tb14008.x.
4
Induction of B1 receptors in vivo in a model of persistent inflammatory mechanical hyperalgesia in the rat.
Neuropharmacology. 1994 Jan;33(1):127-33. doi: 10.1016/0028-3908(94)90107-4.
5
The involvement of bradykinin B1 and B2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat.
Br J Pharmacol. 1994 Sep;113(1):63-8. doi: 10.1111/j.1476-5381.1994.tb16174.x.
6
Mechanism for substance P-induced activation of human neutrophils and eosinophils.
Regul Pept. 1993 Jul 2;46(1-2):228-30. doi: 10.1016/0167-0115(93)90042-7.
7
Substance P-induced inflammation in the rat knee joint is mediated by neurokinin 1 (NK1) receptors.
Regul Pept. 1993 Jul 2;46(1-2):198-201. doi: 10.1016/0167-0115(93)90032-4.
8
NK1 receptors mediate tachykinin-induced increase in microvascular clearance in hamster cheek pouch.
Am J Physiol. 1993 Aug;265(2 Pt 2):H593-8. doi: 10.1152/ajpheart.1993.265.2.H593.
9
A non-peptide NK1-receptor antagonist, RP 67580, inhibits neurogenic inflammation postsynaptically.
Br J Pharmacol. 1993 May;109(1):259-64. doi: 10.1111/j.1476-5381.1993.tb13562.x.
10
Effects of interactions of naturally-occurring neuropeptides on blood flow in the rat knee joint.
Br J Pharmacol. 1993 Mar;108(3):694-9. doi: 10.1111/j.1476-5381.1993.tb12863.x.
Zotero 插件